Immuno-Biological Laboratories Co., Ltd.
4570・Growth Market・Pharmaceuticals
Governance
In June 2026, the company transitioned from a company with a board of corporate auditors to a company with an audit and supervisory committee. The board of directors consists of 7 members (including 4 outside directors and 3 independent officers), adopting a structure aimed at strengthening oversight functions and accelerating decision-making.
Risk Management
The Company has established a Chief Risk Management Officer and conducts company-wide risk management centered on the Board of Directors. It carries out regular education and training based on ISO13485, implements measures against human error, bribery, and cybersecurity risks, and has put in place an internal reporting system to enable early detection and correction of legal violations.
Shareholder Returns
For FY2026 (ending March 2026), an annual dividend of ¥6 (year-end lump sum) was implemented, with a payout ratio of 17.0%. For FY2027 (ending March 2027), the policy is to increase the dividend to an annual ¥7.50 (planned payout ratio of 20.1%). No mention of share buybacks.
Dividend Policy
The policy is to determine dividends by comprehensively considering the trend of past consolidated results, the outlook for future consolidated results, and indicators such as the payout ratio, dividend yield, and equity ratio. For FY2026 (ending March 2026), an annual dividend of ¥6 (year-end lump sum, payout ratio of 17.0%, total dividend amount of ¥55 million) was implemented. For FY2027 (ending March 2027), an annual dividend of ¥7.50 (planned payout ratio of 20.1%) is planned.
ESG
On the environmental front, the company is engaged in initiatives such as introducing LED lighting, installing solar power generation equipment, utilizing electronic manifests, and preserving biodiversity through compliance with the Cartagena Act. In terms of human capital, the company is promoting employee health and diversity, including a female manager ratio of 25.0%, monthly Health and Safety Committee meetings, and the implementation of stress checks.
Last updated: June 26, 2026